How Often Prostate Screening? Everything You Need to Know

Most men should talk with their doctor about prostate screening starting at age 50. If you are Black or have a father or brother who had prostate cancer, start at age 45. If you have more than one close relative with prostate cancer, start at age 40. How often you get screened after that depends on your PSA level and your overall risk. For many men with a normal PSA under 2.5 ng/mL, every two years is enough. For men with a higher PSA or other risk factors, yearly screening is more common. The decision is not one-size-fits-all, and the evidence on screening has shifted over the years. This article breaks down what the research actually says so you can make an informed choice with your doctor.

What Is Prostate Screening and How Does It Work?

Prostate screening usually means two things. The first is a blood test called the PSA test. PSA stands for prostate-specific antigen, a protein made by your prostate gland. When levels are high, it can signal cancer, but it can also signal infection, enlargement, or inflammation. The second test is a digital rectal exam, or DRE, where a doctor feels the prostate through the rectum. This is less common now but still used in some cases.

The PSA test is not perfect. It finds many cancers that would never cause harm. It also misses some aggressive cancers. The goal of screening is to catch dangerous cancers early enough to treat them. The challenge is that screening also finds slow-growing cancers that do not need treatment. This is called overdiagnosis, and it leads to unnecessary biopsies, anxiety, and sometimes treatment side effects.

According to the U.S. Preventive Services Task Force, men aged 55 to 69 should make an individual decision about screening based on their values and risk factors. Men 70 and older should not be screened routinely because the harms likely outweigh the benefits. The American Cancer Society and the American Urological Association have similar but slightly different guidelines. They all agree that the decision should be shared between you and your doctor.

How Often Should You Get a Prostate Screening?

The answer depends on your starting PSA level. For men with a PSA under 2.5 ng/mL, the risk of developing aggressive prostate cancer in the next several years is low. Most guidelines suggest screening every two years for this group. For men with a PSA between 2.5 and 4.0 ng/mL, yearly screening is more common. If your PSA is over 4.0 ng/mL, your doctor will likely recommend further testing, such as a biopsy or an MRI.

Age also matters. The National Comprehensive Cancer Network recommends that men with a life expectancy of less than 10 to 15 years stop screening. This usually means stopping around age 75 for healthy men and earlier for men with serious health conditions. Screening an older man who would not benefit from treatment only exposes him to the harms of unnecessary procedures.

Race and family history change the schedule. Black men are about 70 percent more likely to develop prostate cancer than white men and more than twice as likely to die from it. The American Cancer Society recommends that Black men start screening at age 45. If you have a father or brother diagnosed with prostate cancer, especially before age 65, you are considered high risk and should also start at 45. If you have multiple relatives with prostate cancer, start at 40.

Here is a simple comparison of screening intervals based on risk level:

Does Prostate Screening Actually Save Lives?

Yes, but the effect is modest. The two largest studies on this question are the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the U.S.-based Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. The ERSPC found that screening reduced prostate cancer deaths by about 20 to 25 percent over 16 years. The PLCO trial found no reduction, but that study had serious design problems, including high rates of screening in the control group.

What does this mean in real numbers? The ERSPC data shows that to prevent one death from prostate cancer, you need to invite about 570 men to screening and diagnose about 18 extra cancers. That is a lot of men screened and treated for every life saved. Many of those 18 men will be treated for cancers that would never have killed them.

Research published in the New England Journal of Medicine in 2023 followed men for over 20 years and found that the benefit of screening was concentrated in younger men, particularly those under 65. For men over 70, the benefit was very small or nonexistent. This is why guidelines are shifting toward more selective screening based on age and risk rather than a blanket recommendation for everyone.

It is also worth noting that treatment for prostate cancer has improved since these trials began. Better surgery, radiation, and active surveillance mean that when cancer is found early, the outcomes are better than they were 20 years ago. But this also means that the harms of overdiagnosis are more relevant because we are better at treating low-risk cancers without aggressive therapy.

What Are the Downsides of Prostate Screening?

Screening has real downsides that are often glossed over. The most common is a false positive, meaning a high PSA that turns out not to be cancer. Studies show that after four rounds of yearly screening, about 12 percent of men will have at least one false positive. That leads to a biopsy, which is uncomfortable and carries a small risk of infection or bleeding.

Then there is overdiagnosis. The best estimate from the ERSPC is that about 40 to 50 percent of screen-detected prostate cancers are overdiagnosed. That means they would never have caused symptoms or death in the man’s lifetime. Once diagnosed, many men choose treatment even when active surveillance is an option. Treatment for prostate cancer can cause erectile dysfunction, urinary incontinence, and bowel problems.

Active surveillance is a strategy where low-risk cancers are monitored rather than treated immediately. It is a good option for many men, but it requires regular follow-up PSA tests and sometimes repeat biopsies. Not all men are comfortable with this approach, and some doctors are not great at recommending it. The decision to screen should include a conversation about what happens if cancer is found and whether you are willing to consider active surveillance.

Here are the main harms to be aware of:

• False positive results that lead to unnecessary biopsies
• Overdiagnosis of cancers that would never cause harm
• Side effects from treatment including erectile dysfunction and incontinence
• Anxiety and stress from abnormal results and follow-up testing
• Cost and time of annual doctor visits and blood draws

What Does the Research Say About Newer Screening Methods?

Standard PSA testing is not the only option. Several newer tests aim to reduce overdiagnosis and false positives. The most widely used is the percent free PSA test. PSA in the blood is either bound to proteins or free. Men with prostate cancer tend to have a lower percentage of free PSA. This test can help decide who needs a biopsy when the total PSA is borderline between 4 and 10 ng/mL.

The Prostate Health Index, or PHI, combines total PSA, free PSA, and a precursor form of PSA called proPSA. Studies published in the Journal of Urology show that PHI is more accurate than standard PSA at predicting aggressive prostate cancer. It can reduce unnecessary biopsies by about 30 percent. The test is FDA approved but not always covered by insurance.

Another option is the 4Kscore test, which combines four different PSA-related markers with clinical information like age and DRE results. It gives a percentage risk of finding aggressive cancer on biopsy. Research shows it is better than PSA alone at ruling out high-grade cancer. It is also not always covered by insurance and can cost several hundred dollars out of pocket.

Multiparametric MRI is another tool that is changing prostate cancer diagnosis. Before a biopsy, an MRI can identify suspicious areas in the prostate. If the MRI is clear, some men can safely avoid a biopsy. If it shows a suspicious area, the biopsy can be targeted to that spot rather than taking random samples. This approach is becoming standard in many major medical centers and reduces the diagnosis of low-risk cancers while finding more high-risk ones.

As of 2026, there is no clinical evidence that any of these newer tests should replace PSA as the first step. They are most useful after an abnormal PSA to help decide next steps. If you are concerned about overdiagnosis, ask your doctor whether any of these tests are available and appropriate for you.

Should You Get Screened? How to Decide

This is a personal decision. The evidence shows a small but real benefit in reducing death from prostate cancer, especially for men in their 50s and 60s. The evidence also shows real harms from overdiagnosis and unnecessary treatment. There is no single right answer for every man.

Start by knowing your risk. Do you have a father or brother with prostate cancer? Are you Black? If yes, you are at higher risk and the benefit of screening is larger. If no, you are at average risk and the benefit is smaller. Your overall health and life expectancy matter more than your age alone. If you have a serious health condition that limits your life expectancy to less than 10 years, screening is unlikely to help you.

Think about your values. Are you someone who wants to know everything possible about your health, even if it leads to anxiety and more testing? Or are you someone who would rather avoid unnecessary procedures unless there is a clear problem? Neither answer is wrong, but it should guide your decision.

Talk to your doctor. A good conversation includes your PSA level if you have one, your risk factors, the pros and cons of screening, and what would happen if cancer is found. If your doctor recommends screening without discussing the downsides, ask about them. If your doctor dismisses screening entirely without considering your risk, get a second opinion.

The most important thing is to make an informed decision. Do not just get a PSA test because it is part of your annual blood work without thinking about it. Do not skip it because you heard screening is useless. The truth is somewhere in the middle, and the right choice depends on you.